This study is in progress, not accepting new patients
Combination Therapy of Pegylated Interferon Alfa-2a and Tenofovir Versus Tenofovir Monotherapy in Chronic Hepatitis B
a study on Hepatitis B
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- Mandana Khalili
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Mandana Khalili
Co-Director, Clinical and Translational Science Institute (CTSI)-Comprehensive Mentoring Program My research focuses on natural history of chronic viral hepatitis (hepatitis B and hepatitis C), Alcohol-induced liver injury and pathogenesis of alcoholic and non-alcoholic fatty liver disease, novel treatments for viral hepatitis and fatty liver disease, health services/health di…
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Links
- Hepatitis B Research Network
- ID
- NCT01369212
- Study Type
- Interventional
- Last Updated